Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

182498-32-4 - SB 225002 - 1-(2-Bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea - J65387 - Alfa Aesar

J65387 SB 225002

CAS-Nummer
182498-32-4
Synonyme
1-(2-Bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea

Größe Preis ($) Menge Verfügbarkeit
5mg 120,00
10mg 210,00
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

SB 225002

MDL
MFCD00954637

Chemische Eigenschaften

Formel
C13H10BrN3O4
Molmasse
352.10
Form
Solid
Sensitivität
Moisture Sensitive
Löslichkeit
Soluble to 100mM in DMSO and to 50mM in ethanol

Anwendungen

SB 225002 is a selective non-peptide CXCR2 inhibitor which suppresses IL-8 induced neutrophil chemotaxis and margination. In addition, SB 225002 reduces MPO activity, IL-1β, MIP-2, and keratinocyte-derived chemokine (KC) levels. Further studies suggest that SB 225002 decreases the expression of vascular endothelial growth factor, inducible NOS (NO synthase), and Cox-2 (cyclooxygenase-2 proteins) in colon tissue.

Bemerkungen

Moisture sensitive. Store in cool, dry place in a tightly sealed container. Store away from oxidizing agents, heat, water/ moisture. Store in refrigerator.

Literaturverweise

Julie Catusse; Anne Liotard; Bruno Loillier; Didier Pruneau; Jean-Luc Paquet. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochemical Pharmacology. 2003, 65, (5), 813-821.

John R. White; Judithann M. Lee; Peter R. Young; Robert P. Hertzberg; Anthony J. Jurewicz; Margery A. Chaikin; Katherine Widdowson; James J. Foley; Lenox D. Martin; Don E. Griswold and Henry M. Sarau. Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration. The Journal of Biological Chemistry. 1998, 273, 10095-10098.

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Sicherheitshinweise: P261-P280-P305+P351+P338-P304+P340-P362-P312-P321-P405-P403+P233-P501a

Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Take off contaminated clothing and wash before reuse. Call a POISON CENTER or doctor/physician if you feel unwell. Specific treatment (see label). Store locked up. Store in a well-ventilated place. Keep container tightly closed. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Harmonized Tariff Code
3504.00
TSCA
No

Empfohlen

  • L13985

    Sodium D-glucuronate monohydrate, 99%
  • A12942

    1-Methylisatin, 97%
  • H59899

    3-Methyl-1H-pyrazole-5-carboxylic acid, 97%
  • H33876

    2-Fluoro-4-(trifluoromethoxy)benzonitrile, 97%
  • L11081

    tert-Butyl methyl sulfoxide, tech 85%

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf